Exposure to per- and polyfluoroalkyl substances and glycemic control in older US adults with type 2 diabetes mellitus

The association between blood PFAS concentrations and clinical biochemical measures of organ function and metabolism in participants of the Canadian Health Measures Survey (CHMS)

(2022) Sabit Cakmak et al.   SCIENCE OF THE TOTAL ENVIRONMENT

Thirty-year Trends in Complications in U.S. Adults With Newly Diagnosed Type 2 Diabetes

(2021) Michael Fang et al.   DIABETES CARE

Per- and polyfluoroalkyl substances and kidney function: Follow-up results from the Diabetes Prevention Program trial

(2021) Pi-I D. Lin et al.   ENVIRONMENT INTERNATIONAL

Exposure to isomers of per- and polyfluoroalkyl substances increases the risk of diabetes and impairs glucose-homeostasis in Chinese adults: Isomers of C8 health project

(2021) Mohammed Zeeshan et al.   CHEMOSPHERE

Perfluorooctane sulfonate continual exposure impairs glucose-stimulated insulin secretion via SIRT1-induced upregulation of UCP2 expression

(2021) Xiaoyu Duan et al.   ENVIRONMENTAL POLLUTION

Associations between serum PFOA and PFOS levels and incident chronic kidney disease risk in patients with type 2 diabetes

(2021) Zhaoyang Li et al.   ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY

Exposure to perfluorooctane sulfonate reduced cell viability and insulin release capacity of β cells

(2021) Weiping Qin et al.   Journal of Environmental Sciences-China

Perfluoroalkyl Substances Stimulate Insulin Secretion by Islet β Cells via G Protein-Coupled Receptor 40

(2020) Wei-Ping Qin et al.   ENVIRONMENTAL SCIENCE & TECHNOLOGY

Per- and polyfluoroalkyl substances and obesity, type 2 diabetes and non-alcoholic fatty liver disease: a review of epidemiologic findings

(2020) Weipeng Qi et al.   TOXICOLOGICAL AND ENVIRONMENTAL CHEMISTRY

Perfluorooctane sulfonate acute exposure stimulates insulin secretion via GPR40 pathway

(2020) Lianying Zhang et al.   SCIENCE OF THE TOTAL ENVIRONMENT

Effects of per- and poly-fluorinated alkyl substances on pancreatic and endocrine differentiation of human pluripotent stem cells

(2020) Shuyu Liu et al.   CHEMOSPHERE

Glycemic Control and the Risk of Acute Kidney Injury in Patients With Type 2 Diabetes and Chronic Kidney Disease: Parallel Population-Based Cohort Studies in U.S. and Swedish Routine Care

(2020) Yang Xu et al.   DIABETES CARE

Dysregulated lipid and fatty acid metabolism link perfluoroalkyl substances exposure and impaired glucose metabolism in young adults

(2020) Zhanghua Chen et al.   ENVIRONMENT INTERNATIONAL

Perfluoroalkyl substances are inversely associated with coronary heart disease in adults with diabetes

(2019) Kyoko Honda-Kohmo et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Distribution of novel and legacy per-/polyfluoroalkyl substances in serum and its associations with two glycemic biomarkers among Chinese adult men and women with normal blood glucose levels

(2019) Yishuang Duan et al.   ENVIRONMENT INTERNATIONAL

Economic Costs of Diabetes in the U.S. in 2017

(2018)   DIABETES CARE

Perfluoroalkyl substances and glycemic status in pregnant Danish women: The Odense Child Cohort

(2018) Richard Christian Jensen et al.   ENVIRONMENT INTERNATIONAL

Associations between longitudinal serum perfluoroalkyl substance (PFAS) levels and measures of thyroid hormone, kidney function, and body mass index in the Fernald Community Cohort

(2018) Bevin E. Blake et al.   ENVIRONMENTAL POLLUTION

Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis

(2018) Shreekrishna Lamichane et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Perfluorobutanesulfonic acid disrupts pancreatic organogenesis and regulation of lipid metabolism in the zebrafish, Danio rerio

(2018) Karilyn E Sant et al.   TOXICOLOGICAL SCIENCES

Plasma Concentrations of Per- and Polyfluoroalkyl Substances at Baseline and Associations with Glycemic Indicators and Diabetes Incidence among High-Risk Adults in the Diabetes Prevention Program Trial

(2017) Andres Cardenas et al.   ENVIRONMENTAL HEALTH PERSPECTIVES

PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling

(2017) Mitchell B. Rosen et al.   TOXICOLOGY

A Study of Reverse Causation: Examining the Associations of Perfluorooctanoic Acid Serum Levels with Two Outcomes

(2016) Radhika Dhingra et al.   ENVIRONMENTAL HEALTH PERSPECTIVES

Perfluoroalkyl substances and beta cell deficient diabetes

(2016) Baqiyyah Conway et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants

(2016)   LANCET

Association between perfluoroalkyl acids and kidney function in a cross-sectional study of adolescents

(2015) Anglina Kataria et al.   Environmental Health

Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985–2011: a modelling study

(2014) Edward W Gregg et al.   Lancet Diabetes & Endocrinology

Exposure to Perfluoroalkyl Acids and Markers of Kidney Function among Children and Adolescents Living near a Chemical Plant

(2013) Deborah J. Watkins et al.   ENVIRONMENTAL HEALTH PERSPECTIVES

Perfluorocarbon Emulsions Prevent Hypoxia of Pancreatic β-Cells

(2011) E. Maillard et al.   CELL TRANSPLANTATION

DAGitty

(2011) Johannes Textor et al.   EPIDEMIOLOGY

Immunotoxicity of Perfluorinated Compounds: Recent Developments

(2011) Jamie C. DeWitt et al.   TOXICOLOGIC PATHOLOGY

Pdx1 and other factors that regulate pancreatic β-cell survival

(2009) K. Fujimoto et al.   DIABETES OBESITY & METABOLISM

Association Among Serum Perfluoroalkyl Chemicals, Glucose Homeostasis, and Metabolic Syndrome in Adolescents and Adults

(2008) C.-Y. Lin et al.   DIABETES CARE

Perfluorocarbons: New Tool for Islets Preservation In Vitro

(2008) E. Maillard et al.   TRANSPLANTATION PROCEEDINGS